Speakers 2024

Chief Guest & Keynote Speaker

Judge-Randall-Ray-Rader

Hon. Randall R. Rader (ret.),

Former Chief Judge, United States Court of Appeals for the Federal Circuit

For over 25 years, Judge Rader is a distinguished figure in the realm of IP law and former Chief Judge of the United States Court of Appeals for the Federal Circuit. He has been a leading thought leader in the field of intellectual property law and jurisprudence. His work as Chief Judge, his publications and his work teaching patent law globally to students, judges and government officials has left an indelible mark on the field of IP law and the protection of IP rights throughout the world.
G-V-S-Sesha-Kumar

Dr. GVS Sesha Kumar

Vice President & Head-Intellectual Property, Innovation, Dr. Reddy’s Laboratories

Dr. G V S Sesha Kumar, with over two decades of expertise in managing Intellectual Property in the pharmaceutical industry, holds a Ph.D. in chemistry, an LL.B, and an LL.M in IP law. His strategic acumen has resulted in multimillion-dollar IP wealth across various programs and territories. Sesha focuses on sustainable IP-driven business growth within the pharmaceutical, nutraceutical, and digital therapeutic sectors. His endeavours safeguard Dr. Reddy’s innovation across expanding frontiers while advancing global healthcare.

Pushpendra-Rai-(IAS)

Dr. Pushpendra Rai

IAS, Former Director WIPO

Dr. Pushpendra Rai is an International Intellectual Property (IP) Consultant, advising countries and institutions on different aspects of IP. He was a Director with the World Intellectual Property Organization (WIPO), Geneva, till 2015. As Head of the IP and Economic Development Division, he supervised analytical exercises and implemented programs to assist countries in the strategic use of IP for development. He also successfully concluded the WIPO Development Agenda. In 2009, he headed the WIPO Office in Singapore, supervising activities in the Asia Pacific region.
Shashank

Shashank Upadhye

 Managing Partner, Upadhye Tang LLP

Shashank Upadhye is a recognized leader in the drug development IP/FDA law. He was chief in-house IP/FDA counsel at three leading pharmaceutical and medical device companies. He published 100+ articles, presented at 200+ conferences, and is the sole author of the leading pharma patent infringement and FDA book: Generic Pharmaceutical Patent & FDA Law, now in its 15th Edition (2023-2024).

Sumesh-Reddy

Dr. Sumesh Reddy

Chief Global IP Counsel, Cipla

Dr. Sumesh Reddy is currently the Global Head of Intellectual Property for Cipla Ltd., a Mumbai-based multinational Indian pharmaceutical company. He has been with Cipla since 2015. Prior to joining Cipla, he was senior vice president for Mylan and a member of their core global patent group, responsible for all strategic decision-making related to IP. He has also worked as Senior Director for Dr. Reddy’s Laboratories between 2002-2013 and has been involved with Hatch-Waxman litigation since the early 2000’s. He was one of the founding members of Dr. Reddy’s IP function.

Gautam-Bakshi

Mr. Gautam Bakshi

Head & Patent Counsel – Intellectual Property Management
Unichem Laboratories LTD

Mr. Gautam Bakshi is an IP Attorney, currently working as Head & Patent Counsel – Intellectual Property & Portfolio Management with an Indian Multinational Pharmaceutical Company, Unichem Laboratories Limited. He has rich expertise in the field of IP. His main areas of interest include Identification, Analysis and Management of IP. He is also well versed with the art and skill of IP Prosecution, litigation, licensing, settlements and subsequent procedures thereof.

Arshad-Jamil

Arshad Jamil

VP and Global Head – Intellectual Property Rights
Biocon Biologics LTD

Arshad Jamil is a senior Patent Attorney with extensive experience of more than 2 decades in the legal and IP rights fields. Arshad is Vice President and Global head of IP rights at Biocon Biologics, where he is responsible for devising IP strategy and handling Global Patent litigation for Biosimilars and the Biocon Group’s patent and trademark filings and policy. He manages Biocon group of companies IP portfolio of 1100+ global patents and 2000+ global trademarks. Previously, he was a Senior Patent Attorney at Sun Pharmaceuticals, where he handled ANDA litigations, including Hatch Waxman settlements.

Scroll to Top